Moving lentiviral-based gene therapy into a first-in-man CF trial
Main Authors: | Griesenbach, D, Alton, E, Beekman, J, Boyd, A, Chan, M, Davies, J, Davies, L, Davidson, H, Dekkers, F, Gea-Sorli, S, Gill, D, Hasegawa, M, Higgins, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Stevenson, B, Tsugumine, S |
---|---|
Formato: | Conference item |
Idioma: | English |
Publicado: |
Wiley
2015
|
Títulos similares
-
Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
por: Griesenbach, U, et al.
Publicado: (2016) -
Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
por: Hyde, S, et al.
Publicado: (2015) -
TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
por: Griesenbach, U, et al.
Publicado: (2011) -
Genetic medicines for CF: Hype versus reality
por: Alton, E, et al.
Publicado: (2016) -
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
por: Alton, E, et al.
Publicado: (2016)